Andrew McCaskie

Andrew McCaskie moved to Cambridge in 2013 to take up the Professorship in Orthopaedic Surgery, becoming Head of the Department of Surgery in 2017. He led the bid to establish the Arthritis Research UK Tissue Engineering Centre and became the Director. The Centre brings together many institutions across the UK (University of Cambridge, Newcastle University, the University of Aberdeen, Keele University/the Robert Jones and Agnes Hunt Hospital NHS Foundation Trust in Oswestry, the University of York and the University of Birmingham) bringing together clinicians, engineers and biologists from research and clinical groups to develop regenerative therapies for people with Osteoarthritis. Funded by a core grant of £2.4 million in the first five years and renewed in 2016 (£1.9M) the centre was subsequently renamed; Versus Arthritis; Tissue Engineering and Regenerative Therapies Centre. Professor McCaskie led the Smart Step programme (£1.1M) as part of Stage II UK Regenerative Medicine Platform and is a co-investigator in the recently established UK Regenerative Medicine Platform Hub; Engineered cell environment (£5.1M). His clinical interest is lower limb, particularly hip disease in young patients and he aims to link research to the clinic, for example clinical trials (cell therapy trial for knee arthritis - ADIPOA2 EU €5.9M). He is one of the three editors of Bailey and Love's Short Practice of Surgery 27th Edition and is the Director of the Academic Foundation Programme in Cambridge, establishing the transplant and regeneration theme. He Chairs the Cell Therapy Oversight Committee and represents Addenbrooke’s in the Midlands and Wales Advanced Therapy Treatment Centre. 

External Link

https://www.ukrmp.org.uk/hubs/engineered-cell-environment/